Chronic Constipation in Adults.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36126011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chronic constipation has significant quality-of-life implications. Modifiable risk factors include insufficient physical activity, depression, decreased caloric intake, and aggravating medication use. Chronic constipation is classified as primary (normal transit, slow transit, defecatory disorders, or a combination) or secondary (due to medications, chronic diseases, or anatomic abnormalities). Evaluation begins with a detailed history, medication reconciliation, and physical examination. Routine use of laboratory studies or imaging, including colonoscopy, is not recommended in the absence of alarm symptoms. Patients with alarm symptoms or who are overdue for colorectal cancer screening should be referred for colonoscopy. First-line treatment for primary constipation includes ensuring adequate fluid intake, dietary fiber supplementation, and osmotic laxatives. Second-line therapy includes a brief trial of stimulant laxatives followed by intestinal secretagogues. If the initial treatment approach is ineffective, patients should be referred to gastroenterology for more specialized testing, such as anorectal manometry and a balloon expulsion test. Patients with refractory constipation may be considered for surgery. Those in whom pelvic floor dysfunction is identified early should be referred for pelvic floor therapy with biofeedback while first-line medications, such as bulk or osmotic laxatives, are initiated.
Medical subject headings
- Laxatives
- Secretagogues